About 700 reports

  • 2.8.3 TARGETED THERAPIES
  • 6.4.3 MARKET SIZE
  • Cancer
  • Targeted Therapy
  • World
  • Market Size
  • Merck & Co., Inc.
  • Diagnosed prevalence and treated pool for targeted therapies to increase over the forecast period
  • 7.1.2 INCREASING AWARENESS AND DIAGNOSIS
  • Targeted Therapy
  • Asia
  • World
  • Market Size
  • Novartis AG
  • 2.7.3.2 Targeted Therapy
  • 7.2.2 DEALS BY STAGE OF DEVELOPMENT AND VALUE
  • Targeted Therapy
  • World
  • Market Size
  • Celgene Corporation
  • Novartis AG
  • NEW THERAPIES INCREASE MARKET SEGMENTATION AND DIVERSIFY TREATMENT
  • 6.3.2 ANNUAL COST OF THERAPY

Targeted Therapy in Lung Cancer: IPASS and Beyond, Keeping Abreast of the Explosion of Targeted Therapies for Lung Cancer.

  • Targeted Therapy
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novartis AG
  • Roche Group
  • 2.6.4 TARGETED THERAPIES
  • Non-hematological Cancer, Global, Key Marketed Products and Approved Indications, 2015
  • Targeted Therapy
  • World
  • Market Size
  • Bristol-Myers Squibb Company
  • Novartis AG
  • 3.2 HER2-Targeted Therapy
  • 6.7 Japan
  • Targeted Therapy
  • World
  • Market Size
  • AstraZeneca PLC
  • Roche Group

Targeted Therapies in Asthma - 2017 ##.

  • Respiratory Treatment
  • Targeted Therapy
  • France
  • Germany
  • United States
  • BCMA TARGETED THERAPIES: DEVELOPMENT PIPELINE,
  • BCMA TARGETED THERAPIES: DISTRIBUTION BY INDICATION
  • Targeted Therapy
  • United States
  • Affimed Therapeutics AG
  • Amgen Inc.
  • Celgene Corporation

Targeted Therapies in Asthma: KOL Insight: Update Bulletin [April 2017] This edition presents key opinion leader (KOL) views on recent developments in the targeted asthma treatment market Topics covered include; GlaxoSmithKline’s (GSK) presentation of new data at

  • Monoclonal Antibody
  • Respiratory Treatment
  • Targeted Therapy
  • Therapy
  • United States

Targeted Therapies In Asthma: Update Bulletin [April 2016] This edition presents key opinion leader (KOL) views on recent developments in the asthma market, including the clinical role of Nucala (mepolizumab; GSK) the prospects for Teva’s recently approved Cinqair (reslizumab) and

  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • 4 MAJOR MAB-TARGETING THERAPY AREAS
  • 2.1 INITIAL MAB DEVELOPMENT
  • Targeted Therapy
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Genentech, Inc.
  • Johnson & Johnson
  • MOST PRESCRIBED TARGETED THERAPIES FOR MCRC, BY SEGMENT IN THE 8MM, 2016
  • AVAILABLE
  • Targeted Therapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • TARGETED THERAPY
  • Market landscape
  • Targeted Therapy
  • Amgen Inc.
  • Celgene Corporation
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • GROWING DEMAND FOR TARGETED THERAPIES
  • LUNG CANCER THERAPEUTICS MARKET IN AMERICAS
  • Targeted Therapy
  • AstraZeneca PLC
  • Celgene Corporation
  • Eli Lilly & Co.
  • Hoffmann-La Roche Inc.
  • OPPORTUNITY REMAINS FOR THE DEVELOPMENT OF NOVEL TARGETED THERAPIES
  • DEVELOPMENT STRATEGIES FOCUS ON IMPROVING TARGETED THERAPY OPTIONS
  • Targeted Therapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Targeted Therapy Drug Import
  • Targeted Therapy Drug
  • Targeted Therapy
  • China
  • ACON Biotech Co., Ltd
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Targeted Therapy Drug Sales Volume and Market
  • Targeted Therapy Drug Major Producer and Their
  • Targeted Therapy
  • China
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Beijing Novartis Pharma Ltd
  • Targeted Therapy Drug Sales Volume (million Yuan)
  • Targeted Therapy Drug Sales Volume by Drugs Classification in 2016(percent)
  • Targeted Therapy
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Entry of Novel Targeted Therapies and Triple-Combination Therapies to Expand Treatment Options
  • Executive Summary
  • Targeted Therapy
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG
  • 2.6.3 HORMONAL THERAPIES
  • UROLOGIC ONCOLOGY THERAPEUTICS MARKET, GLOBAL, REVENUE FORECAST FOR PROSTVAC

Targeted therapies in the treatment of renal cell carcinoma.

  • Targeted Therapy
  • World
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Pfizer Inc.
  • Targeted Therapy Drug Sales Volume (million Yuan)
  • Targeted Therapy Drug Sales Volume by Drugs Classification in 2016(percent)
  • Targeted Therapy
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Fourteen: Multiple Myeloma 222
  • Five: Brain Cancer
  • Targeted Therapy
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • 7.5 TARGETED THERAPIES FOR NON-CLEAR CELL RCC
  • 10.3.3 Bayer
  • Targeted Therapy
  • Eisai Co., Ltd.
  • Exelixis, Inc.
  • Pfizer Inc.
  • Roche Group
  • 9.6.2 MOLECULAR TARGETED THERAPIES
  • BRAF, MEK AND C-KIT TARGETED THERAPIES
  • Targeted Therapy
  • Therapy
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group
  • 2.8.4 TARGETED THERAPIES
  • Strong Market Growth Expected, Driven by Targeted Therapy Approvals and New Market Entries and Increasing Cancer Prevalence
  • Targeted Therapy
  • World
  • Celgene Corporation
  • Novartis AG
  • Pfizer Inc.
  • MARKET SEGMENTATION BY END-USER
  • EMERGENCE OF TARGETED AND COMBINATION THERAPIES FOR BREAST CANCER

Targeted therapies specifically target cancer cells without harming normal cells.

  • Targeted Therapy
  • Amgen Inc.
  • Biocon Limited
  • Mylan Inc.
  • Roche Group
  • 7.2.1 HIGH LEVEL OF COMPETITION
  • 7.2.4 MULTIPLE DRUGS TO LOSE PATENT PROTECTION IN FORECAST PERIOD
  • Targeted Therapy
  • Asia
  • World
  • Novartis AG
  • Pfizer Inc.

Cyclin Dependent Kinase (CDK) Inhibitors are considered as promising and immensely effective targeted therapy of the future as it aims at targeting the tumor cell formation at its root level, before it can progress to affect other healthy cells of the body.

  • Cancer
  • Targeted Therapy
  • Therapy
  • World
  • 09.3 TARGETED THERAPY
  • 20.3 SWOT ANALYSIS OF TARGETED THERAPIES
  • Targeted Therapy
  • Celgene Corporation
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Hoffmann-La Roche Inc.
  • 2.8.4 TARGETED THERAPIES
  • A) Treatment Patterns
  • Targeted Therapy
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.